KFRX-06

N/A

Report date: 2024/01/16 14:57:10

Base Information

Drug NameKFRX-06
Drug Alias NameKFRX-06KFRX06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase inhibitors
TargetsReceptor protein-tyrosine kinase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKeifeRx LLCGeorgetown University
China Registration ClassN/A

Develop Information

Active CompaniesGeorgetown UniversityAmneal PharmaceuticalsKeifeRx LLC
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A